FLAVOXATE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Flavoxate Hydrochloride patents expire, and what generic alternatives are available?
Flavoxate Hydrochloride is a drug marketed by Epic Pharma, Impax Pharms, and Padagis Us. and is included in three NDAs.
The generic ingredient in FLAVOXATE HYDROCHLORIDE is flavoxate hydrochloride. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the flavoxate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flavoxate Hydrochloride
A generic version of FLAVOXATE HYDROCHLORIDE was approved as flavoxate hydrochloride by PADAGIS US on December 16th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLAVOXATE HYDROCHLORIDE?
- What are the global sales for FLAVOXATE HYDROCHLORIDE?
- What is Average Wholesale Price for FLAVOXATE HYDROCHLORIDE?
Summary for FLAVOXATE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Clinical Trials: | 3 |
| Patent Applications: | 954 |
| DailyMed Link: | FLAVOXATE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for FLAVOXATE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Calgary | Phase 4 |
| Mahidol University | Phase 4 |
| Padagis LLC | Phase 1 |
Pharmacology for FLAVOXATE HYDROCHLORIDE
| Drug Class | Cholinergic Muscarinic Antagonist |
| Mechanism of Action | Cholinergic Muscarinic Antagonists |
Medical Subject Heading (MeSH) Categories for FLAVOXATE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for FLAVOXATE HYDROCHLORIDE
US Patents and Regulatory Information for FLAVOXATE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma | FLAVOXATE HYDROCHLORIDE | flavoxate hydrochloride | TABLET;ORAL | 076835-001 | Nov 30, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Impax Pharms | FLAVOXATE HYDROCHLORIDE | flavoxate hydrochloride | TABLET;ORAL | 076234-001 | Aug 28, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Padagis Us | FLAVOXATE HYDROCHLORIDE | flavoxate hydrochloride | TABLET;ORAL | 076831-001 | Dec 16, 2004 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
